dr. brahmer discusses response to immunotherapy
Published 10 years ago • 26 plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
0:58
dr. brahmer discusses the outlook for immunotherapies
-
1:21
dr. julie brahmer on the pd-1 targeted immunotherapy bms-93655 clinical trial
-
1:16
dr. brahmer on distinguishing between immunotherapy response and cancer growth
-
2:03
dr. brahmer discusses tumor vaccines for lung cancer
-
1:32
dr. brahmer on the benefit of immunotherapy in metastatic nsclc
-
1:56
dr. brahmer discusses the future of antibodies for lung cancer
-
1:41
dr. brahmer discusses second-line pembrolizumab in nsclc
-
26:09
how to treat cutaneous melanoma (skin cancer) - dr. allison betof warner
-
0:58
dr. julie r. brahmer on immunotherapy development in lung cancer
-
1:15
dr. brahmer on immunotherapy beyond pd-1/l1 in nsclc
-
1:59
dr. brahmer on side effects of immunotherapy for lung cancer
-
1:53
dr. brahmer on the role of pd-1 and pd-l1
-
1:23
dr. brahmer on biomarkers for immune response in nsclc
-
1:21
julie brahmer, md, discusses considerations when choosing between immunotherapy and chemotherapy
-
1:48
dr. brahmer discusses frontline single-agent pembrolizumab in lung cancer
-
0:31
copy of dr. brahmer on the role of immunotherapy in metastatic nsclc
-
6:11
dr. brahmer reviews lung cancer in 2017
-
1:29
dr. brahmer on managing immune-related aes in lung cancer
-
1:00:52
immunotherapy for lung cancer: what patients need to know, with julie brahmer